Combination lipid therapy in type 2 diabetes
Sacks, F.M.; Carey, V.J.; Fruchart, J-Charles.
New England Journal of Medicine 363(7): 692
2010
ISSN/ISBN: 0028-4793 PMID: 20842772 Document Number: 646338
Document emailed within 1 workday
Related Documents
Statsenko, M.E.; Derevianchenko, M.V.; Ostrovskiĭ, O.V.; Titarenko, M.N.; Shvets, M.K.; Bondarev, A.M. 2013: Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus Terapevticheskii Arkhiv 85(9): 63-68Shubrook, J.H. 2018: Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy Journal of Family Practice 67(8 Suppl): S49-S54
Wolffenbuttel, B.H.; Huijberts, M.S. 2001: Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2 Nederlands Tijdschrift Voor Geneeskunde 145(16): 761-765
Chearskul, S.; Sangurai, S.; Nitiyanant, W.; Kriengsinyos, W.; Kooptiwut, S.; Harindhanavudhi, T. 2007: Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus Journal of the Medical Association of Thailand 90(10): 2150-2157
Kirk, J.K.; Pearce, K.A.; Michielutte, R.; Summerson, J.H. 1999: Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes? Journal of Family Practice 48(11): 879-882
Pinkhasov, B.B.; Seliatitskaia, V.G.; Mitrofanov, I.M.; Anufrienko, A.V.; Dolgova, N.A. 2014: Combination of arterial hypertension and type 2 diabetes mellitus with obesity Klinicheskaia Meditsina 92(9): 65-69
DeWitt, D.E.; Hirsch, I.B. 2003: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review JAMA 289(17): 2254-2264
Okada, S.; Ishii, K.; Tanokuchi, S.; Hamada, H.; Ichiki, K.; Ota, Z. 1995: Effect of alpha-glucosidase inhibitor in combination with sulphonylurea compounds on lipid profile in patients with non-insulin-dependent diabetes mellitus Journal of International Medical Research 23(6): 492-496
Peerapatdit, T.; Likidlilid, A.; Patchanans, N.; Somkasetrin, A. 2006: Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus Journal of the Medical Association of Thailand 89(Suppl 5): S141-S146
Klebanova, E.M.; Balabolkin, M.I.; Kreminskaia, V.M.; Smirnov, L.D. 2006: Lipid reducing and antioxidant action of mexicor in patients with diabetes mellitus type 2 Terapevticheskii Arkhiv 78(8): 67-70
Lebedeva, E.A. 1991: Relationship between serum selenium level and lipid spectrum in patients with diabetes mellitus type i Problemy Endokrinologii 37(6): 23-25
Gómez García, M.ía.T.; Aguarón Benitez, G.; Barberá Belda, B.; Callejón Rodríguez, C.; González Merlo, G. 2012: Medical therapy (methotrexate and mifepristone) alone or in combination with another type of therapy for the management of cervical or interstitial ectopic pregnancy European Journal of Obstetrics Gynecology and Reproductive Biology 165(1): 77-81
Otieno, C.F.; Mwendwa, F.W.; Vaghela, V.; Ogola, E.N.; Amayo, E.O. 2005: Lipid profile of ambulatory patients with type 2 diabetes mellitus at Kenyatta National Hospital, Nairobi East African Medical Journal 82(12 Suppl): S173-S179
Casteels, K.; Waer, M.; Bouillon, R.; Allewaert, K.; Laureys, J.; Mathieu, C. 1996: Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A Transplantation Proceedings 28(6): 3095
Lukich, B.L.; Kakhnovskiĭ, I.M.; Kurakina, L.V.; Murakhovskiĭ, K.K. 1994: Effect of hyperbaric oxygenation on the dynamics of carbohydrate and lipid metabolism in the blood of patients with type i diabetes mellitus Klinicheskaia Meditsina 72(3): 46-50
Tkacheva, O.N.; Barabashkina, A.V.; Novikova, I.M.; Runikhina, N.K. 2009: The study of effects of ramipril and amlodipine combination in patients with arterial hypertension and type 2 diabetes mellitus Kardiologiia 49(5): 40-47
Ballary, C.; Desai, A. 2003: Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study Journal of the Indian Medical Association 101(2): 113-114; 123
Hintz, R.; Grajnert, K.; Drewnowska, I. 1977: Basic lipid indices and concentration of beta and prebeta lipoproteins in the serum of patients with adult-type diabetes mellitus Polski Tygodnik Lekarski 32(22): 825-827
Bhosle, D.; Chavan, S.; Kardile, S. 2021: Efficacy and Safety of Empagliflozin as Add on in Patients with Type Ii Diabetes Mellitus (DM) Inadequately Controlled on Triple Drug Combination Journal of the Association of Physicians of India 69(12): 11-12
Tao, S.; Tian, L.; Fu, M.; Tian, H. 2013: Studies of influences of blood glucose controlling on the changes of lipid profiles, ApoB100, ApoAi and HDL subclass of newly diagnosed type 2 diabetes Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 30(2): 368-374